Saad, Fred <br/><br/>
Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer.  [electronic resource] 

 -  Seminars in oncology  Jun 2010 
 - S38-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1532-8708 
<br/><br/><label>Standard No.: </label>10.1053/j.seminoncol.2010.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--prevention & control<br/>Carcinoma, Renal Cell--drug therapy<br/>Diphosphonates--therapeutic use<br/>Disease Progression<br/>Humans<br/>Imidazoles--therapeutic use<br/>Kidney Neoplasms--drug therapy<br/>Survival Analysis<br/>Urinary Bladder Neoplasms--drug therapy<br/>Zoledronic Acid